Role of circulating tumor DNA to help decision-making in hepatocellular carcinoma
Oncoscience
.
2018 Aug 22;5(7-8):209-211.
doi: 10.18632/oncoscience.446.
eCollection 2018 Jul.
Authors
Johann von Felden
1
,
Amanda J Craig
1
,
Augusto Villanueva
1
Affiliation
1
Division of Liver Diseases, Division of Hematology and Medical Oncology, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA.
PMID:
30234139
PMCID:
PMC6142901
DOI:
10.18632/oncoscience.446
No abstract available
Keywords:
biomarker; liquid biopsy; liver cancer; next-generation sequencing; prediction.
Grants and funding
P30 CA196521/CA/NCI NIH HHS/United States
T32 CA078207/CA/NCI NIH HHS/United States